Recent Company News

• 07:35 AM ET Mar 11, 2025
  

  Brainsway reports Q4 EPS $0.04 vs FactSet $0.02 [4 est, $0.02-0.03] ($9.19, 0.00)

• 10:11 AM ET Feb 18, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (193 total)

• 10:11 AM ET Feb 14, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (202 total)

• 08:06 AM ET Dec 12, 2024
  

  Brainsway reports positive independent pilot data on accelerated deep TMS treatment of alcohol use disorder ($9.81, 0.00)

• 08:03 AM ET Nov 20, 2024
  

  Brainsway reports promising feasibility data showing pain reduction with deep TMS Therapy ($9.67, 0.00)

• 09:21 AM ET Nov 12, 2024
  

  StreetAccount Summary - US Pre-market trading update

• 08:19 AM ET Nov 12, 2024
  

  StreetAccount Summary - US Pre-market trading

• 07:43 AM ET Nov 12, 2024
  

  Brainsway reports Q3 EPS $0.02 vs FactSet $0.01 [4 est, $0.00-0.02] ($10.80, 0.00)

• 10:07 AM ET Nov 11, 2024
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (547 total)

• 10:12 AM ET Nov 07, 2024
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (268 total)